Stoke Therapeutics, Inc. · NASDAQ:STOK
Allan Jonathan sold 627 Stoke Therapeutics, Inc. shares (Form 4)
Traded Oct 2, 2026 · Filed Oct 2, 2026
On Oct 2, 2026, Allan Jonathan (GENERAL COUNSEL & CORP SEC) sold 627 Stoke Therapeutics, Inc. shares at US$26.33 for US$16,509 under a trading plan, leaving 20,598 shares. Filed Oct 2, 2026 (Form 4).
- Sold
- 627 shares
- Price
- US$26.33
- Value
- US$16,509
- Holding after
- 20,598 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- GENERAL COUNSEL & CORP SEC
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Common Stock | Sale | 627 | US$26.33 | 20,598 | Direct |
Source
Related
- Stoke Therapeutics, Inc.
- Allan Jonathan
- Stoke Therapeutics, Inc. shareholders
- Form 4 · Allan Jonathan · Aug 18, 2026
- Form 4 · Allan Jonathan · Jun 18, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Biotechnology Value Fund L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026
- Form 4 · Kaye Edward M. MD · Aug 18, 2026